Skip to main content
Journal cover image

Use of phenelzine in continuation therapy.

Publication ,  Journal Article
Davidson, J; Raft, D
Published in: Neuropsychobiology
1984

In 18 depressed patients, phenelzine had proved to be a beneficial drug during treatment of the acute illness. Following 4 weeks' remission induced by either 45 or 60 mg/day, patients were assigned to take part in a double-blind study in which the dose either remained fixed at the original dose, or was decreased by 15 mg/month and eventually replaced by placebo. 15 patients completed the study. Patients who remained at the same dose did significantly better on measures of anxiety and depression. The dropout rate ('relapse' rate) also differed significantly between the two dose groups. It is concluded that in this group of patients, maintenance of the full dose of phenelzine is recommended for at least 6 months.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Neuropsychobiology

DOI

ISSN

0302-282X

Publication Date

1984

Volume

11

Issue

3

Start / End Page

191 / 194

Location

Switzerland

Related Subject Headings

  • Psychiatry
  • Psychiatric Status Rating Scales
  • Phenelzine
  • Long-Term Care
  • Humans
  • Drug Administration Schedule
  • Double-Blind Method
  • Dose-Response Relationship, Drug
  • Depressive Disorder
  • 1702 Cognitive Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Davidson, J., & Raft, D. (1984). Use of phenelzine in continuation therapy. Neuropsychobiology, 11(3), 191–194. https://doi.org/10.1159/000118076
Davidson, J., and D. Raft. “Use of phenelzine in continuation therapy.Neuropsychobiology 11, no. 3 (1984): 191–94. https://doi.org/10.1159/000118076.
Davidson J, Raft D. Use of phenelzine in continuation therapy. Neuropsychobiology. 1984;11(3):191–4.
Davidson, J., and D. Raft. “Use of phenelzine in continuation therapy.Neuropsychobiology, vol. 11, no. 3, 1984, pp. 191–94. Pubmed, doi:10.1159/000118076.
Davidson J, Raft D. Use of phenelzine in continuation therapy. Neuropsychobiology. 1984;11(3):191–194.
Journal cover image

Published In

Neuropsychobiology

DOI

ISSN

0302-282X

Publication Date

1984

Volume

11

Issue

3

Start / End Page

191 / 194

Location

Switzerland

Related Subject Headings

  • Psychiatry
  • Psychiatric Status Rating Scales
  • Phenelzine
  • Long-Term Care
  • Humans
  • Drug Administration Schedule
  • Double-Blind Method
  • Dose-Response Relationship, Drug
  • Depressive Disorder
  • 1702 Cognitive Sciences